Gv 2017 Gp, L.L.C. - Jul 25, 2025 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
10%+ Owner
Signature
/s/ Inga Goldbard, General Counsel of GV 2017 GP, L.L.C.
Stock symbol
VERV
Transactions as of
Jul 25, 2025
Transactions value $
$0
Form type
4
Date filed
7/28/2025, 05:19 PM
Previous filing
Nov 8, 2022

Reporting Owners (10)

Name Relationship Address Signature Signature date CIK
GV 2017 GP, L.L.C. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Inga Goldbard, General Counsel of GV 2017 GP, L.L.C. 2025-07-28 0001733338
GV 2017 GP, L.P. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Inga Goldbard, General Counsel of GV 2017 GP, L.P. 2025-07-28 0001733339
GV 2017, L.P. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ /s/ Inga Goldbard, General Counsel of GV 2017, L.P. 2025-07-28 0001733340
GV 2019 GP, L.L.C. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Inga Goldbard, General Counsel of GV 2019 GP, L.L.C. 2025-07-28 0001845038
GV 2019 GP, L.P. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Inga Goldbard, General Counsel of GV 2019 GP, L.P. 2025-07-28 0001845039
GV 2019, L.P. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Inga Goldbard, General Counsel of GV 2019, L.P. 2025-07-28 0001845041
GV 2023 GP, L.L.C. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Inga Goldbard, General Counsel of GV 2023 GP, L.L.C. 2025-07-28 0001961991
GV 2023 GP, L.P. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Inga Goldbard, General Counsel of GV 2023 GP, L.P. 2025-07-28 0001961990
GV 2023, L.P. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Inga Goldbard, General Counsel of GV 2023, L.P. 2025-07-28 0001961979
Alphabet Inc. 10%+ Owner 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW /s/ Kathryn W. Hall, Secretary of Alphabet Inc. 2025-07-28 0001652044

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Disposition pursuant to a tender of shares in a change of control transaction -6.11M -100% 0 Jul 25, 2025 By GV 2017 L.P. F1, F2, F3
transaction VERV Common Stock Disposition pursuant to a tender of shares in a change of control transaction -4.26M -100% 0 Jul 25, 2025 By GV 2019 L.P. F1, F2, F4
transaction VERV Common Stock Disposition pursuant to a tender of shares in a change of control transaction -1.8M -100% 0 Jul 25, 2025 By GV 2023, L.P. F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Gv 2017 Gp, L.L.C. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 In connection with the terms of an Agreement and Plan of Merger, dated as of June 16, 2025 (the "Merger Agreement"), by and among the Issuer, Eli Lilly and Company ("Parent") and Parent's indirect wholly owned subsidiary, Ridgeway Acquisition Corporation ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock (the "Common Stock"). In exchange for each share, tendering stockholders received: (i) $10.50 per share, net to the stockholder in cash, without interest and less any applicable tax withholding (the "Cash Consideration"); plus (ii) one non-tradable contingent value right (each, a "CVR" and, together with the Cash Consideration, the "Offer Price"), which represents the contractual right to receive a contingent payment of up to $3.00 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of a certain specified milestone relating to the Issuer's business,
F2 (continued from footnote 1) in accordance with the terms and subject to the conditions and other provisions of a contingent value rights agreement entered into by and among Parent, the Purchaser, and Computershare Inc. and its affiliate, Computershare Trust Company, N.A., as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the "Merger"), effective as of July 25, 2025, with the Issuer continuing as the surviving entity and an indirect wholly owned subsidiary of Parent.
F3 The securities reported in this row are directly held by GV 2017, L.P. (the "2017 Partnership"). The general partner of the 2017 Partnership is GV 2017 GP, L.P. (the "2017 GP"). The general partner of the 2017 GP is GV 2017 GP, L.L.C. ("GV 2017 LLC"). The sole member of GV 2017 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2017 GP, GV 2017 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2017 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F4 The securities reported in this row are directly held by GV 2019, L.P. (the "2019 Partnership"). The general partner of the 2019 Partnership is GV 2019 GP, L.P. (the "2019 GP"). The general partner of the 2019 GP is GV 2019 GP, L.L.C. ("GV 2019 LLC"). The sole member of GV 2019 LLC is Alphabet Holdings. The sole member of Alphabet Holdings is XXVI. The controlling stockholder of XXVI is Alphabet Inc. Each of the 2019 GP, GV 2019 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2019 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F5 The securities reported in this row are directly beneficially owned by GV 2023, L.P. (the "2023 Partnership"). GV 2023 GP, L.P. (the "2023 GP") is the general partner of the 2023 Partnership. GV 2023 GP, L.L.C. ("GV 2023 LLC") is the general partner of the 2023 GP. Alphabet Holdings is the sole member of GV 2023 LLC. XXVI is the sole member of Alphabet Holdings. Alphabet Inc. is the controlling stockholder of XXVI. Each of the 2023 GP, GV 2023 LLC, Alphabet Holdings, XXVI and Alphabet Inc. may be deemed to have voting and investment discretion over the securities directly beneficially owned by the 2023 Partnership. Each of the 2023 GP, GV 2023 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.